HomeCompareFOCPX vs JNJ

FOCPX vs JNJ: Dividend Comparison 2026

FOCPX yields 8.43% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FOCPX wins by $14.9K in total portfolio value
10 years
FOCPX
FOCPX
● Live price
8.43%
Share price
$22.39
Annual div
$1.89
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.0K
Annual income
$1,436.64
Full FOCPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FOCPX vs JNJ

📍 FOCPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFOCPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FOCPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FOCPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FOCPX
Annual income on $10K today (after 15% tax)
$716.75/yr
After 10yr DRIP, annual income (after tax)
$1,221.14/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FOCPX beats the other by $517.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FOCPX + JNJ for your $10,000?

FOCPX: 50%JNJ: 50%
100% JNJ50/50100% FOCPX
Portfolio after 10yr
$27.5K
Annual income
$1,132.21/yr
Blended yield
4.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FOCPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FOCPX buys
0
JNJ buys
0
No recent congressional trades found for FOCPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFOCPXJNJ
Forward yield8.43%3.36%
Annual dividend / share$1.89$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$35.0K$20.0K
Annual income after 10y$1,436.64$827.78
Total dividends collected$11.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FOCPX vs JNJ ($10,000, DRIP)

YearFOCPX PortfolioFOCPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,543$843.23$10,676$355.77+$867.00FOCPX
2$13,261$909.69$11,407$389.39+$1.9KFOCPX
3$15,166$976.69$12,198$426.53+$3.0KFOCPX
4$17,271$1,043.91$13,056$467.62+$4.2KFOCPX
5$19,591$1,111.07$13,987$513.12+$5.6KFOCPX
6$22,141$1,177.87$14,998$563.56+$7.1KFOCPX
7$24,935$1,244.05$16,098$619.52+$8.8KFOCPX
8$27,989$1,309.38$17,295$681.69+$10.7KFOCPX
9$31,322$1,373.64$18,599$750.82+$12.7KFOCPX
10$34,952$1,436.64$20,022$827.78+$14.9KFOCPX

FOCPX vs JNJ: Complete Analysis 2026

FOCPXStock

The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities principally traded on NASDAQ® or an over-the-counter (OTC) market, which has more small and medium-sized companies than other markets. The fund invests more than 25% of total assets in the technology sector. It invests in domestic and foreign issuers. The fund invests in either growth stocks or value stocks or both. It is non-diversified.

Full FOCPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FOCPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FOCPX vs SCHDFOCPX vs JEPIFOCPX vs OFOCPX vs KOFOCPX vs MAINFOCPX vs ABBVFOCPX vs MRKFOCPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.